This combination pairs Semaglutide, a GLP-1 receptor agonist, with BPC-157, a peptide studied for its cellular support properties. Research explores how Semaglutide’s metabolic and appetite-regulating effects may complement BPC-157’s role in promoting tissue integrity and cellular response. The blend is of interest for studies examining metabolic function and gastrointestinal health.
